Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.9702
-0.0287 (-2.87%)
At close: May 13, 2025, 4:00 PM
0.9500
-0.0202 (-2.08%)
Pre-market: May 14, 2025, 6:21 AM EDT

Silexion Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2013 FY 2012
Period Ending
Dec '24 Dec '23 Dec '13 Dec '12
Cash & Equivalents
1.194.60.791.6
Cash & Short-Term Investments
1.194.60.791.6
Cash Growth
-74.17%483.12%-50.69%-
Other Receivables
--0.090.16
Receivables
--0.090.16
Prepaid Expenses
0.970.340.01-
Restricted Cash
0.040.03--
Other Current Assets
0.060.020.040.03
Total Current Assets
2.254.980.931.79
Property, Plant & Equipment
0.560.250.010.01
Other Long-Term Assets
0.050.03--
Total Assets
2.865.260.941.8
Accounts Payable
0.930.320.10.08
Accrued Expenses
1.431.570.140.09
Short-Term Debt
1---
Current Portion of Leases
0.160.11--
Other Current Liabilities
00.2--
Total Current Liabilities
3.522.20.240.17
Long-Term Debt
2.96---
Long-Term Leases
0.370.06--
Total Liabilities
6.852.260.240.17
Common Stock
0---
Additional Paid-In Capital
39.2611.345.164.74
Retained Earnings
-43.25-26.81-4.47-3.11
Total Common Equity
-3.99-15.480.71.63
Minority Interest
-3.42--
Shareholders' Equity
-3.9930.71.63
Total Liabilities & Equity
2.865.260.941.8
Total Debt
4.490.17--
Net Cash (Debt)
-3.34.420.791.6
Net Cash Growth
-461.42%-50.69%-
Net Cash Per Share
-5.3039.6047.57112.00
Filing Date Shares Outstanding
8.410.110.150.15
Total Common Shares Outstanding
1.850.110.150.15
Working Capital
-1.272.780.691.62
Book Value Per Share
-2.16-138.524.6710.91
Tangible Book Value
-3.99-15.480.71.63
Tangible Book Value Per Share
-2.16-138.524.6710.91
Machinery
0.10.080.020.01
Leasehold Improvements
-0.06--
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q